Sign in Register

Egrifta (tesamorelin acetate)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

USES: This medication is used to reduce excess fat in the stomach area (abdomen) in people with HIV infection who have changes in the way their body fat is distributed. Some HIV drugs may cause this side effect (increased fat in the upper back and stomach areas, decreased fat in the arms and legs). Tesamorelin works by causing your body to make more growth hormone.

This medication should not be used for weight loss.

Generic name: tesamorelin acetate
Pronunciation: (TES-a-moe-REL-in)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Egrifta

Intelligence content is not available yet.

Indications

The following indications are listed for Egrifta:

  • Lipodystrophy Associated With Human Immunodeficiency Virus Infection

Dosing

No dosing information is available for this tab.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data